However, lipoprotein-associated phospholipase A2 (Lp-PLA2) and myeloperoxidase (MPO) are more relevant to coronary disease, as they target plaque-specific processes, such as the hydrolysis of oxidized phospholipids and neutrophil activation. This evidence concerns the gene MPO and coronary artery disorder.